Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients
Gregory F. Oxenkrug, Marieke van der Hart, Julien Roeser, et al.
Integrative Clinical Medicine (2017) Vol. 1, Iss. 1
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease
Yaping Shao, Weidong Le
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 208
The Plasma [Kynurenine]/[Tryptophan] Ratio and Indoleamine 2,3-Dioxygenase: Time for Appraisal
Abdulla A.‐B. Badawy, Gilles J. Guillemin
International Journal of Tryptophan Research (2019) Vol. 12
Open Access | Times Cited: 178
Kynurenine Pathway in Diabetes Mellitus—Novel Pharmacological Target?
Kamila Kozieł, Ewa M. Urbańska
Cells (2023) Vol. 12, Iss. 3, pp. 460-460
Open Access | Times Cited: 62
The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments
Abbas F. Almulla, Asara Vasupanrajit, Chavit Tunvirachaisakul, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 9, pp. 3679-3691
Open Access | Times Cited: 63
Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis
Bing Cao, Yan Chen, Zhongyu Ren, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 123, pp. 203-214
Closed Access | Times Cited: 57
Dysregulated tryptophan metabolism contributes to metabolic syndrome in Chinese community-dwelling older adults
Shujing Sun, Fang-ting Hu, Yanru Sang, et al.
BMC Endocrine Disorders (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Pu-erh Tea Restored Circadian Rhythm Disruption by Regulating Tryptophan Metabolism
Shanshan Hu, Liyong Luo, Xintong Bian, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 18, pp. 5610-5623
Closed Access | Times Cited: 37
Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study
Pratishtha Chatterjee, Kathryn Goozee, Chai K. Lim, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 54
A six-metabolite panel as potential blood-based biomarkers for Parkinson’s disease
Stephan Klatt, James D. Doecke, Anne Roberts, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 41
The Footprint of Kynurenine Pathway in Neurodegeneration: Janus-Faced Role in Parkinson’s Disorder and Therapeutic Implications
Tapan Behl, Ishnoor Kaur, Aayush Sehgal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6737-6737
Open Access | Times Cited: 40
Tryptophan Metabolism Is Associated with BMI and Adipose Tissue Mass and Linked to Metabolic Disease in Pediatric Obesity
Julia Lischka, Andrea Schanzer, Margot Baumgartner, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 286-286
Open Access | Times Cited: 26
Peripheral Tryptophan – Kynurenine Metabolism Associated with Metabolic Syndrome is Different in Parkinson’s and Alzheimer’s Diseases
Gregory F. Oxenkrug, Marieke van der Hart, Julien Roeser, et al.
(2017) Vol. 1, Iss. 4
Open Access | Times Cited: 42
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Parkinson’s Disease in Mouse: Potential Association between Neurotransmitter Disturbance and Gut Microbiota Dysbiosis
Yuanhui Zhu, Fei Huan, Junfeng Wang, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 20, pp. 3366-3376
Closed Access | Times Cited: 39
Blood-based kynurenine pathway alterations in schizophrenia spectrum disorders: A meta-analysis
Manuel Morrens, Livia De Picker, Jarl K. Kampen, et al.
Schizophrenia Research (2020) Vol. 223, pp. 43-52
Closed Access | Times Cited: 29
Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging the Dogma
Korrapati V. Sathyasaikumar, Verónica Pérez de la Cruz, Benjamín Pineda, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 315-315
Open Access | Times Cited: 19
Biological Susceptibility of Patients with Schizophrenia to Metabolic Syndrome: A Review
Jun Ma, Zhengyuan Huang, Jing Chen, et al.
ALPHA PSYCHIATRY (2025) Vol. 26, Iss. 2
Closed Access
A zebrafish model of acmsd deficiency does not support a prominent role for ACMSD in Parkinson’s disease
Emma Fargher, Marcus Keatinge, Oliver Pearce, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
<p>Increased Plasma Kynurenic Acid Levels are Associated with Impaired Attention/Vigilance and Social Cognition in Patients with Schizophrenia</p>
Xingbing Huang, Wenhua Ding, Fengchun Wu, et al.
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 263-271
Open Access | Times Cited: 27
Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings
Handan Noyan, Ece Erdağ, Erdem Tüzün, et al.
Schizophrenia Research (2021) Vol. 229, pp. 27-37
Closed Access | Times Cited: 21
The dangerous “West Coast Swing” by hyperglycaemia and chronic stress in the mouse hippocampus: Role of kynurenine catabolism
Micaela Gliozzi, Anna Rita Coppoletta, Antonio Cardamone, et al.
Pharmacological Research (2024) Vol. 201, pp. 107087-107087
Open Access | Times Cited: 3
Kynurenine‐3‐monooxygenase: A new direction for the treatment in different diseases
Yifei Lü, Mingmei Shao, Tao Wu
Food Science & Nutrition (2020) Vol. 8, Iss. 2, pp. 711-719
Open Access | Times Cited: 21
Identifying potential dietary treatments for inherited metabolic disorders using Drosophila nutrigenomics
Felipe Martelli, Jiayi Lin, Sarah Mele, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113861-113861
Open Access | Times Cited: 2
Kynurenic Acid Protects Against Ischemia/Reperfusion-Induced Retinal Ganglion Cell Death in Mice
Rooban B. Nahomi, Mi-Hyun Nam, Johanna Rankenberg, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 5, pp. 1795-1795
Open Access | Times Cited: 18
Benserazide, an Inhibitor of Peripheral Kynurenine Metabolism, Attenuates Olanzapine-Induced Weight Gain, Insulin Resistance, and Dyslipidemia in C57Bl/6j Mice
Gregory F. Oxenkrug, Paul Summergrad
Molecular Neurobiology (2019) Vol. 57, Iss. 1, pp. 135-138
Closed Access | Times Cited: 14
Obesity and Diabetes: Pathophysiology of Obesity-Induced Hyperglycemia and Insulin Resistance
Gaurav Gupta, Ridhima Wadhwa, Parijat Pandey, et al.
Springer eBooks (2020), pp. 81-97
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top